Forest Stands Tall As Wall Street Chops 15% Off Rx Stocks
Executive Summary
Forest's plan to extricate the antidepressant Celexa from a successful co-promotion deal has made the company the unlikely early winner on Wall Street in the bidding war over Warner-Lambert.
You may also be interested in...
Merck Builds Risk Management Into Drug Development; Hires FDA’s Honi
Merck is building risk management into its product development strategy with the hiring of FDA Office of Drug Safety Director Peter Honig, MD
Merck Builds Risk Management Into Drug Development; Hires FDA’s Honi
Merck is building risk management into its product development strategy with the hiring of FDA Office of Drug Safety Director Peter Honig, MD
Glaxo SmithKline U.S. Marketing Could Reach 250,000 MDs In One Week
The combined Glaxo SmithKline U.S. sales force would be able to call on 250,000 physicians during the first week of a major product launch, the companies told a Jan. 17 London press briefing on their proposed merger.